1
40
14
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1097/MJT.0b013e3181f94c16" target="_blank" rel="noreferrer noopener">http://doi.org/10.1097/MJT.0b013e3181f94c16</a>
Pages
255–260
Issue
4
Volume
19
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Utilization of a reminder mailing to improve blood glucose log reporting in an outpatient diabetes clinic.
Publisher
An entity responsible for making the resource available
American Journal of Therapeutics
Date
A point or period of time associated with an event in the lifecycle of the resource
2012
2012-07
Subject
The topic of the resource
Adult; Female; Male; Aged; Prospective Studies; Patient Compliance; Human; Middle Age; Retrospective Design; Mail; Reminder Systems; Ambulatory Care – Methods; Hypoglycemic Agents – Therapeutic Use; Blood Glucose Self-Monitoring – Methods; Diabetes Mellitus – Drug Therapy
Creator
An entity primarily responsible for making the resource
Moorman JM; Frazee L A; Dillon ML; Chomo DL; Myers NA
Description
An account of the resource
Self-monitored blood glucose (SMBG) offers a strategy used to achieve glycemic control in diabetic patients. However, if SMBG readings are unavailable to clinicians, this strategy will have a limited effect. This study assessed the impact of a reminder mailing on response rates to requests for SMBG logs. Patients were asked to mail completed SMBG logs to the clinic in 2 weeks. For the intervention, a reminder mailing was sent to each patient 1 week before SMBG logs were to be returned. Compliance rates pre and postinterventions were compared. The primary outcome was the percentage of all SMBG logs returned on time. Secondary outcomes included the percentage of SMBG logs returned, percentage fulfilled, percentage of clinic appointments kept, percentage of SMBG logs brought to follow-up appointments, and number of interventions made to antidiabetic therapy. Twenty SMBG requests were made in the preintervention cohort versus 19 in postintervention cohort. A trend toward more on time and fulfilled SMBG requests was observed post vs. preintervention. Overall return rates were similar between groups. A nonsignificant increase in clinic appointments kept and a nonsignificant decrease in interventions made were observed postintervention. Receipt of a reminder mail was not a significant predictor of patients bringing an SMBG log to follow-up appointments. In conclusion, the use of a reminder mail was not associated with an increase in the return rate of SMBG logs, although there were nonsignificant trends toward more on time and fulfilled SMBG logs received during the postintervention period.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1097/MJT.0b013e3181f94c16" target="_blank" rel="noreferrer noopener">10.1097/MJT.0b013e3181f94c16</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2012
Adult
Aged
Ambulatory Care – Methods
American journal of therapeutics
Blood Glucose Self-Monitoring – Methods
Chomo DL
Department of Family & Community Medicine
Department of Internal Medicine
Department of Pharmaceutical Sciences
Department of Pharmacy Practice
Diabetes Mellitus – Drug Therapy
Dillon ML
Female
Frazee L A
Human
Hypoglycemic Agents – Therapeutic Use
Mail
Male
Middle Age
Moorman JM
Myers NA
NEOMED College of Medicine
NEOMED College of Pharmacy
Patient Compliance
Prospective Studies
Reminder Systems
Retrospective Design
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1345/aph.1K531" target="_blank" rel="noreferrer noopener">http://doi.org/10.1345/aph.1K531</a>
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Pages
403-407
Issue
3
Volume
42
Search for Full-text
Locate full-text within NEOMED Library's e-journal collections
<p>Users with a NEOMED Library login can search for full-text journal articles at the following url: <a href="https://libraryguides.neomed.edu/home">https://libraryguides.neomed.edu/home</a></p>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Use Of Intravenous Valproic Acid For Acute Migraine
Publisher
An entity responsible for making the resource available
Annals of Pharmacotherapy
Date
A point or period of time associated with an event in the lifecycle of the resource
2008
2008-03
Subject
The topic of the resource
headache; migraine headache; Pharmacology & Pharmacy; sodium valproate; valproic acid
Creator
An entity primarily responsible for making the resource
Frazee L A; Foraker K C
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1345/aph.1K531" target="_blank" rel="noreferrer noopener">10.1345/aph.1K531</a>
Format
The file format, physical medium, or dimensions of the resource
Journal Article or Conference Abstract Publication
2008
Annals of Pharmacotherapy
Department of Internal Medicine
Foraker K C
Frazee L A
Headache
Migraine headache
NEOMED College of Medicine
Pharmacology & Pharmacy
sodium valproate
valproic acid
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1592/phco.26.3.353" target="_blank" rel="noreferrer noopener">http://doi.org/10.1592/phco.26.3.353</a>
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Pages
353-359
Issue
3
Volume
26
Search for Full-text
Locate full-text within NEOMED Library's e-journal collections
<p>Users with a NEOMED Library login can search for full-text journal articles at the following url: <a href="https://libraryguides.neomed.edu/home">https://libraryguides.neomed.edu/home</a></p>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Update On Prostate Cancer Chemoprevention
Publisher
An entity responsible for making the resource available
Pharmacotherapy
Date
A point or period of time associated with an event in the lifecycle of the resource
2006
2006-03
Subject
The topic of the resource
5-alpha-reductase inhibitors; antigen; beta-carotene; chemoprevention; clinical trial; dutasteride; finasteride; men; nonsteroidal antiinflammatory drugs; over-expression; PCPT; Pharmacology & Pharmacy; prevention; prostate cancer; REDUCE trial; REDUCE trial; risk; SELECT; selenium level
Creator
An entity primarily responsible for making the resource
Lowe J F; Frazee L A
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1592/phco.26.3.353" target="_blank" rel="noreferrer noopener">10.1592/phco.26.3.353</a>
Format
The file format, physical medium, or dimensions of the resource
Journal Article or Conference Abstract Publication
2006
5-alpha-reductase inhibitors
Antigen
beta-carotene
Chemoprevention
Clinical Trial
Department of Internal Medicine
dutasteride
finasteride
Frazee L A
Lowe J F
men
NEOMED College of Medicine
nonsteroidal antiinflammatory drugs
over-expression
PCPT
Pharmacology & Pharmacy
Pharmacotherapy
Prevention
Prostate cancer
REDUCE trial
Risk
SELECT
selenium level
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1097/00000441-200009000-00015" target="_blank" rel="noreferrer noopener">http://doi.org/10.1097/00000441-200009000-00015</a>
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Pages
214-218
Issue
3
Volume
320
Search for Full-text
Locate full-text within NEOMED Library's e-journal collections
<p>Users with a NEOMED Library login can search for full-text journal articles at the following url: <a href="https://libraryguides.neomed.edu/home">https://libraryguides.neomed.edu/home</a></p>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Subtherapeutic International Normalized Ratio Despite Increasing Doses Of Warfarin: Could This Be Malabsorption?
Publisher
An entity responsible for making the resource available
American Journal of the Medical Sciences
Date
A point or period of time associated with an event in the lifecycle of the resource
2000
2000-09
Subject
The topic of the resource
azathioprine; drug-interaction; General & Internal Medicine; patient; resistance; therapy; warfarin malabsorption; warfarin resistance
Creator
An entity primarily responsible for making the resource
Lara L F; Delgado L L; Frazee L A; Haupt K M; Rutecki G W
Description
An account of the resource
Objective: To describe a case of warfarin resistance apparently caused by malabsorption and to review the literature regarding warfarin resistance. Case Summary: A 28-year-old renal transplant patient with systemic lupus erythematosus was admitted for upper extremity thrombophlebitis. Resistance to oral warfarin was demonstrated. Potential causes were investigated. The trapezoidal rule was used to compare the area under the curve for intravenous versus oral dosing of warfarin. The usual bioavailability of warfarin should be 100%. in this patient, warfarin bioavailability after oral dosing was 1.5%. Three potential causes, malabsorption (FF), enzymatic degradation (FC), and first-pass extraction in the portal circulation (FH), are discussed. Conclusion: This case demonstrates resistance to warfarin presumably caused by malabsorption.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1097/00000441-200009000-00015" target="_blank" rel="noreferrer noopener">10.1097/00000441-200009000-00015</a>
Format
The file format, physical medium, or dimensions of the resource
Journal Article or Conference Abstract Publication
2000
American Journal of the Medical Sciences
azathioprine
Delgado L L
Department of Family & Community Medicine
Department of Internal Medicine
drug-interaction
Frazee L A
General & Internal Medicine
Haupt K M
Journal Article or Conference Abstract Publication
Lara L F
NEOMED College of Medicine
Patient
resistance
Rutecki G W
therapy
warfarin malabsorption
warfarin resistance
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1097/01.mjt.0000174345.59177.9b" target="_blank" rel="noreferrer noopener">http://doi.org/10.1097/01.mjt.0000174345.59177.9b</a>
Pages
18–23
Issue
1
Volume
13
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Screening for nephropathy and antiangiotensin use among diabetic patients in an academic community medical center.
Publisher
An entity responsible for making the resource available
American Journal of Therapeutics
Date
A point or period of time associated with an event in the lifecycle of the resource
2006
2006-01
Subject
The topic of the resource
Female; Male; Aged; Age Factors; Drug Utilization; Academic Medical Centers; Diabetes Mellitus; Human; Middle Age; Practice Guidelines; Retrospective Design; Professional Compliance; Type 2 – Drug Therapy; Type 2 – Complications; Hypertension – Diagnosis; Coronary Arteriosclerosis – Diagnosis; Angiotensin-Converting Enzyme Inhibitors – Therapeutic Use; Angiotensin II Type I Receptor Blockers – Therapeutic Use; Diabetic Nephropathies – Diagnosis; Diabetic Nephropathies – Epidemiology; Diabetic Nephropathies – Etiology; Hypertension – Drug Therapy; Proteinuria – Diagnosis; Type 1 – Complications; Type 1 – Drug Therapy
Creator
An entity primarily responsible for making the resource
Frazee L A; Samandari S; Tanphaichitr N; Bourguet C C; Pfister EW
Description
An account of the resource
The American Diabetes Association recommends routine screening for albuminuria to detect early nephropathy in all patients with diabetes mellitus. If nephropathy is identified, treatment with an antiangiotensin agent decreases progression and improves renal outcomes. Concordance with guidelines for nephropathy screening and antiangiotensin therapy among diabetic patients in a primary care setting of an academic community medical center was evaluated. Medical charts of adult patients with diabetes mellitus from February 2000 through January 2003 were retrospectively reviewed. In part 1 of the study, whether patients were screened for nephropathy at least once was recorded. In part 2 of the study, antiangiotensin prescribing was assessed in all patients and in subgroups stratified by screening. In both parts of the study, patient characteristics and comorbidities were assessed using multivariate analysis to determine their impact on the odds that a patient was screened and that antiangiotensin therapy was prescribed. Among the 329 patients included, 182 patients (55.3%) were screened for nephropathy. Patients who were screened were younger (OR=0.83 for 10-year increase, 95% CI: 0.69-0.99), less likely to have congestive heart failure (OR=0.42, 95% CI: 0.20-0.90), and more likely to be cared for by a resident physician directly supervised by an attending physician (OR=3.03; 95% CI: 1.82-5.03). A total of 215 patients (65.3%) were prescribed antiangiotensin therapy. Hypertension was a predictor of antiangiotensin therapy among all patients who were screened (OR=10.34, 95% CI: 4.45-24.01), those who were screened and negative (OR=15.46, 95% CI: 5.56-42.98), and those who were not screened (OR=10.79, 95% CI: 4.39-26.52). Among patients screened for nephropathy, coronary artery disease (OR=3.01, 95% CI: 1.05-8.63), and the presence of proteinuria (OR=4.26, 95% CI: 1.61-11.24) were predictors of antiangiotensin use. This study found that the likelihood of screening for nephropathy among diabetic patients was inversely associated with a diagnosis of congestive heart failure and increasing age. Conversely, care by a resident physician directly supervised by an attending physician increased the odds that patients would be screened. A diagnosis of hypertension and the presence of albuminuria were each associated with increased use of an antiangiotensin agent.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1097/01.mjt.0000174345.59177.9b" target="_blank" rel="noreferrer noopener">10.1097/01.mjt.0000174345.59177.9b</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2006
Academic Medical Centers
Age Factors
Aged
American journal of therapeutics
Angiotensin II Type I Receptor Blockers – Therapeutic Use
Angiotensin-Converting Enzyme Inhibitors – Therapeutic Use
Bourguet C C
Coronary Arteriosclerosis – Diagnosis
Department of Internal Medicine
Diabetes Mellitus
Diabetic Nephropathies – Diagnosis
Diabetic Nephropathies – Epidemiology
Diabetic Nephropathies – Etiology
Drug Utilization
Female
Frazee L A
Human
Hypertension – Diagnosis
Hypertension – Drug Therapy
Male
Middle Age
NEOMED College of Medicine
Pfister EW
Practice Guidelines
Professional Compliance
Proteinuria – Diagnosis
Retrospective Design
Samandari S
Tanphaichitr N
Type 1 – Complications
Type 1 – Drug Therapy
Type 2 – Complications
Type 2 – Drug Therapy
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1097/MJT.0b013e3180ed4345" target="_blank" rel="noreferrer noopener">http://doi.org/10.1097/MJT.0b013e3180ed4345</a>
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Pages
111-118
Issue
2
Volume
15
Search for Full-text
Locate full-text within NEOMED Library's e-journal collections
<p>Users with a NEOMED Library login can search for full-text journal articles at the following url: <a href="https://libraryguides.neomed.edu/home">https://libraryguides.neomed.edu/home</a></p>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Retrospective Evaluation Of A Method To Predict Fresh-frozen Plasma Dosage In Anticoagulated Patients
Publisher
An entity responsible for making the resource available
American Journal of Therapeutics
Date
A point or period of time associated with an event in the lifecycle of the resource
2008
2008-03
Subject
The topic of the resource
anticoagulation reversal; dose prediction; efficacy; factor viia; fresh-frozen plasma; hemostasis; Pharmacology & Pharmacy; prothrombin complex concentrate; therapy; transfusion; urgent reversal; warfarin
Creator
An entity primarily responsible for making the resource
Frazee L A; Bourguet C C; Gutierrez W; Elder-Arrington J; Elackattu A E P; Haller N A
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1097/MJT.0b013e3180ed4345" target="_blank" rel="noreferrer noopener">10.1097/MJT.0b013e3180ed4345</a>
Format
The file format, physical medium, or dimensions of the resource
Journal Article or Conference Abstract Publication
2008
American journal of therapeutics
anticoagulation reversal
Bourguet C C
Department of Internal Medicine
dose prediction
efficacy
Elackattu A E P
Elder-Arrington J
factor viia
Frazee L A
fresh-frozen plasma
Gutierrez W
Haller N A
Hemostasis
NEOMED College of Medicine
Pharmacology & Pharmacy
prothrombin complex concentrate
therapy
transfusion
urgent reversal
warfarin
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1345/aph.1D355" target="_blank" rel="noreferrer noopener">http://doi.org/10.1345/aph.1D355</a>
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Pages
490-493
Issue
3
Volume
38
Search for Full-text
Locate full-text within NEOMED Library's e-journal collections
<p>Users with a NEOMED Library login can search for full-text journal articles at the following url: <a href="https://libraryguides.neomed.edu/home">https://libraryguides.neomed.edu/home</a></p>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Management of asymptomatic bacteriuria in patients with diabetes mellitus
Publisher
An entity responsible for making the resource available
Annals of Pharmacotherapy
Date
A point or period of time associated with an event in the lifecycle of the resource
2004
2004-03
Subject
The topic of the resource
bacteriuria; diabetes mellitus; Pharmacology & Pharmacy; urinary-tract infections; women
Creator
An entity primarily responsible for making the resource
Ooi S T; Frazee L A; Gardner W G
Description
An account of the resource
OBJECTIVE: To review the literature regarding the management of asymptomatic bacteriuria (ASB) in patients with diabetes mellitus. DATA SOURCES: A MEDLINE (1967-June 2003) and bibliographic search of the English-language literature was conducted using the search terms diabetes mellitus, asymptomatic, bacteriuria, and urinary tract infection. DATA SYNTHESIS: ASB occurs in diabetic women more commonly than in non-diabetics and is associated with an increased risk of symptomatic urinary tract infection (UTI) among patients with type 2 diabetes. Symptomatic UTIs tend to follow a more complicated course in diabetics. Despite these independent observations, antimicrobial therapy has not been shown to reduce symptomatic UTIs, pyelonephritis, or hospitalization for UTI. CONCLUSIONS: Available evidence does not support antimicrobial treatment of ASB among patients with diabetes mellitus.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1345/aph.1D355" target="_blank" rel="noreferrer noopener">10.1345/aph.1D355</a>
Format
The file format, physical medium, or dimensions of the resource
Journal Article
2004
Annals of Pharmacotherapy
bacteriuria
Department of Internal Medicine
Diabetes Mellitus
Frazee L A
Gardner W G
Journal Article
NEOMED College of Medicine
Ooi S T
Pharmacology & Pharmacy
urinary-tract infections
Women
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1345/aph.1E585" target="_blank" rel="noreferrer noopener">http://doi.org/10.1345/aph.1E585</a>
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Pages
908-912
Issue
5
Volume
39
Search for Full-text
Locate full-text within NEOMED Library's e-journal collections
<p>Users with a NEOMED Library login can search for full-text journal articles at the following url: <a href="https://libraryguides.neomed.edu/home">https://libraryguides.neomed.edu/home</a></p>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Long-term Prophylaxis Of Spontaneous Bacterial Peritonitis In Patients With Cirrhosis
Publisher
An entity responsible for making the resource available
Annals of Pharmacotherapy
Date
A point or period of time associated with an event in the lifecycle of the resource
2005
2005-05
Subject
The topic of the resource
1st episode; antibiotic-prophylaxis; antimicrobial; ascites; ascitic fluid; cirrhosis; double-blind; gastrointestinal hemorrhage; infection; opsonic activity; peritonitis; Pharmacology & Pharmacy; predictive factors; prevention; randomized-trial
Creator
An entity primarily responsible for making the resource
Frazee L A; Marinos A E; Rybarczyk A M; Fulton S A
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1345/aph.1E585" target="_blank" rel="noreferrer noopener">10.1345/aph.1E585</a>
Format
The file format, physical medium, or dimensions of the resource
Journal Article or Conference Abstract Publication
1st episode
2005
Annals of Pharmacotherapy
antibiotic-prophylaxis
Antimicrobial
ascites
ascitic fluid
Cirrhosis
Department of Internal Medicine
double-blind
Frazee L A
Fulton S A
gastrointestinal hemorrhage
Infection
Marinos A E
NEOMED College of Medicine
opsonic activity
peritonitis
Pharmacology & Pharmacy
predictive factors
Prevention
randomized-trial
Rybarczyk A M
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1345/aph.1C486" target="_blank" rel="noreferrer noopener">http://doi.org/10.1345/aph.1C486</a>
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Pages
1489-1496
Issue
10
Volume
37
Search for Full-text
Locate full-text within NEOMED Library's e-journal collections
<p>Users with a NEOMED Library login can search for full-text journal articles at the following url: <a href="https://libraryguides.neomed.edu/home">https://libraryguides.neomed.edu/home</a></p>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Duration Of Anticoagulant Therapy After Initial Idiopathic Venous Thromboembolism
Publisher
An entity responsible for making the resource available
Annals of Pharmacotherapy
Date
A point or period of time associated with an event in the lifecycle of the resource
2003
2003-10
Subject
The topic of the resource
anticoagulation; antiphospholipid syndrome; deep-vein thrombosis; duration of therapy; factor-v-leiden; first episode; heterozygous carriers; idiopathic venous thromboembolism; intensity warfarin therapy; long-term; medical progress; Pharmacology & Pharmacy; pulmonary-embolism; risk; warfarin
Creator
An entity primarily responsible for making the resource
Frazee L A; Chomo D L
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1345/aph.1C486" target="_blank" rel="noreferrer noopener">10.1345/aph.1C486</a>
Format
The file format, physical medium, or dimensions of the resource
Journal Article or Conference Abstract Publication
2003
Annals of Pharmacotherapy
Anticoagulation
antiphospholipid syndrome
Chomo D L
deep-vein thrombosis
Department of Internal Medicine
duration of therapy
factor-v-leiden
first episode
Frazee L A
heterozygous carriers
idiopathic venous thromboembolism
intensity warfarin therapy
long-term
medical progress
NEOMED College of Medicine
Pharmacology & Pharmacy
pulmonary-embolism
Risk
warfarin
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
1265–1274
Issue
5
Volume
37
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Drug-induced acute renal failure: recognizing and treating prerenal, postrenal, and pseudorenal injury.
Publisher
An entity responsible for making the resource available
Consultant (00107069)
Date
A point or period of time associated with an event in the lifecycle of the resource
1997
1997-05
Subject
The topic of the resource
Female; Male; Aged; Risk Factors; Hemodynamics; Physical Examination; Inpatients; Middle Age; Kidney Function Tests; Kidney Failure; Nephrotoxicity; Antiinflammatory Agents; Acute – Etiology; Angiotensin-Converting Enzyme Inhibitors – Adverse Effects; Antineoplastic Agents – Adverse Effects; Non-Steroidal – Adverse Effects; Acute – Chemically Induced; Acute – Diagnosis; Acute – Therapy; Enzyme Inhibitors – Adverse Effects; Renal Circulation – Drug Effects
Creator
An entity primarily responsible for making the resource
Frazee L A; Rutecki G W; Whittier F C
Description
An account of the resource
Angiotensin-converting enzyme (ACE) inhibitors and NSAIDs are among the drugs most commonly associated with acute renal failure (ARF). Patients at risk for ACE inhibitor-induced ARF include those with congestive heart failure (CHF) or compromised left ventricular (IV) function and those receiving diuretics. In these settings, discontinue the ACE inhibitor and direct therapy toward correcting volume or improving the ineffective circulation (by appropriately reducing afterload, by ensuring adequate IV filling pressures, and by treating ischemia). Risk factors for NSAID-included ARF include CHI, poor renal perfusion, and recent hospitalization. Postrenal ARF may be precipitated by drugs that are highly insoluble in addic urine, such as antineoplastic agents and HmG-CoA reductase inhibitors. Alkalinization of urine and hydration are the cornerstones of management of this type of ARF.
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
1997
Acute – Chemically Induced
Acute – Diagnosis
Acute – Etiology
Acute – Therapy
Aged
Angiotensin-Converting Enzyme Inhibitors – Adverse Effects
Antiinflammatory Agents
Antineoplastic Agents – Adverse Effects
Consultant (00107069)
Department of Internal Medicine
Enzyme Inhibitors – Adverse Effects
Female
Frazee L A
Hemodynamics
Inpatients
Kidney Failure
Kidney Function Tests
Male
Middle Age
NEOMED College of Medicine
nephrotoxicity
Non-Steroidal – Adverse Effects
Physical Examination
Renal Circulation – Drug Effects
Risk Factors
Rutecki G W
Whittier F C
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
1592–1599
Issue
6
Volume
37
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Drug-induced acute renal failure: keys to recognizing and treating intrarenal toxicity.
Publisher
An entity responsible for making the resource available
Consultant (00107069)
Date
A point or period of time associated with an event in the lifecycle of the resource
1997
1997-06
Subject
The topic of the resource
Adult; Female; Male; Aged; Risk Factors; Kidney Function Tests; Kidney Failure; Physiologic; Monitoring; Nephrotoxicity; Antiinflammatory Agents; Non-Steroidal – Adverse Effects; Acute – Chemically Induced; Acute – Diagnosis; Acute – Therapy; Aminoglycosides – Adverse Effects; Amphotericin B – Adverse Effects; Contrast Media – Adverse Effects; Drugs – Adverse Effects; Nephrotoxicity – Prevention and Control
Creator
An entity primarily responsible for making the resource
Frazee L A; Rutecki G W; Whittier F C
Description
An account of the resource
Drug-induced acute tubular necrosis is a primary cause of acute renal failure (ARF); it may result from the use of such agents as aminoglycosides, amphotericin B, and radilocontrast media. To reduce the risk of aminoglycoside toxicity, prescribe the shortest course possible, use once-daily dosing, monitor serum concentrations, and avoid using these agents altogether in patients with known risk factors. Radiocontrast media-associated ARF is most likely to occur with preexisting renal damage, especially in a patient with diabetes mellitus. Since sodium depletion is the most important risk factor for nephrotoxic injury with amphotericin B use, saline loading is recommended both before and during drug administration. Drug-induced acute interstitial nephritis, another important cause of ARF, has been associated with a number of antibiotics, especially penicillin and ampicillin; many patients recover with the removal of the offending agent.
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
1997
Acute – Chemically Induced
Acute – Diagnosis
Acute – Therapy
Adult
Aged
Aminoglycosides – Adverse Effects
Amphotericin B – Adverse Effects
Antiinflammatory Agents
Consultant (00107069)
Contrast Media – Adverse Effects
Department of Internal Medicine
Drugs – Adverse Effects
Female
Frazee L A
Kidney Failure
Kidney Function Tests
Male
Monitoring
NEOMED College of Medicine
nephrotoxicity
Nephrotoxicity – Prevention and Control
Non-Steroidal – Adverse Effects
Physiologic
Risk Factors
Rutecki G W
Whittier F C
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1097/MJT.0b013e3181d48320" target="_blank" rel="noreferrer noopener">http://doi.org/10.1097/MJT.0b013e3181d48320</a>
Pages
300–304
Issue
4
Volume
18
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Comparison of short-acting intramuscular antipsychotic medication: impact on length of stay and cost.
Publisher
An entity responsible for making the resource available
American Journal of Therapeutics
Date
A point or period of time associated with an event in the lifecycle of the resource
2011
2011-07
Subject
The topic of the resource
Adult; Female; Male; Prospective Studies; Health Care Costs; Injections; Middle Age; Retrospective Design; Intramuscular; Antiinfective Agents; Length of Stay – Statistics and Numerical Data; Schizophrenia – Drug Therapy; Heterocyclic Compounds – Therapeutic Use; Antianxiety Agents; Antipsychotic Agents – Administration and Dosage; Antipsychotic Agents – Economics; Antipsychotic Agents – Therapeutic Use; Benzodiazepine – Economics; Benzodiazepine – Therapeutic Use; Haloperidol – Economics; Haloperidol – Therapeutic Use; Heterocyclic Compounds – Economics; Length of Stay – Economics; Psychomotor Agitation – Drug Therapy; Quinolone – Economics; Quinolone – Therapeutic Use; Thiazoles – Economics; Thiazoles – Therapeutic Use
Creator
An entity primarily responsible for making the resource
Leung JG; Benedetti AM; Frazee L A; Myers N; Leung Jonathan G; Benedetti Amanda M; Frazee Lawrence A; Myers Nancy
Description
An account of the resource
A retrospective cohort study was conducted to determine if there is an association between short-acting intramuscular (SAIM) antipsychotics used for acute agitation and length of stay (LOS). Patients with a diagnosis of schizophrenia or schizoaffective disorder who were dispensed at least one dose of a SAIM antipsychotic were divided into groups based on the initial SAIM antipsychotic received once admitted to a psychiatric unit. Electronic records were used to gather demographic information, LOS, and number of injections received during an admission. Cost was calculated from the number of injections received. One-hundred and thirty-six patients were enrolled. When comparing the haloperidol group to the second generation antipsychotic group, there was no statistically significant difference, in LOS 16.98 ± 9.56 days versus 17.59 ± 11.52 days (P = 0.75), respectively. There was a statistically significant difference in both cost and number of injections between groups, favoring the haloperidol group. Ziprasidone was associated with a shorter LOS compared with olanzapine, 13.57 and 19.10 days, respectively (P = 0.026). Patient characteristics should be evaluated when determining an agent for acute agitation. However, because literature indicates second generation SAIM antipsychotics are only noninferior to haloperidol; other factors should also be evaluated; including impact on LOS and impact on hospital resources. This study indicates use of a second generation SAIM antipsychotic for acute agitation is more costly, requires more injections, and was not associated with a shorter length of stay when compared with SAIM haloperidol.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1097/MJT.0b013e3181d48320" target="_blank" rel="noreferrer noopener">10.1097/MJT.0b013e3181d48320</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2011
Adult
American journal of therapeutics
Antianxiety Agents
Antiinfective Agents
Antipsychotic Agents – Administration and Dosage
Antipsychotic Agents – Economics
Antipsychotic Agents – Therapeutic Use
Benedetti AM
Benedetti Amanda M
Benzodiazepine – Economics
Benzodiazepine – Therapeutic Use
Department of Family & Community Medicine
Department of Internal Medicine
Female
Frazee L A
Frazee Lawrence A
Haloperidol – Economics
Haloperidol – Therapeutic Use
Health Care Costs
Heterocyclic Compounds – Economics
Heterocyclic Compounds – Therapeutic Use
Injections
Intramuscular
Length of Stay – Economics
Length of Stay – Statistics and Numerical Data
Leung JG
Leung Jonathan G
Male
Middle Age
Myers N
Myers Nancy
NEOMED College of Medicine
Prospective Studies
Psychomotor Agitation – Drug Therapy
Quinolone – Economics
Quinolone – Therapeutic Use
Retrospective Design
Schizophrenia – Drug Therapy
Thiazoles – Economics
Thiazoles – Therapeutic Use
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1097/mjt.0b013e3181bdc3d0" target="_blank" rel="noreferrer noopener">http://doi.org/10.1097/mjt.0b013e3181bdc3d0</a>
Pages
313–322
Issue
4
Volume
18
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Cinacalcet for the treatment of primary hyperparathyroidism.
Publisher
An entity responsible for making the resource available
American Journal of Therapeutics
Date
A point or period of time associated with an event in the lifecycle of the resource
2011
2011-07
Subject
The topic of the resource
Female; Hormone Replacement Therapy; Hydrocarbons – Therapeutic Use; Bone Density – Drug Effects; Calcitonin – Therapeutic Use; Diphosphonates – Therapeutic Use; Estrogens – Therapeutic Use; Hormone Antagonists – Pharmacodynamics; Hormone Antagonists – Therapeutic Use; Hydrocarbons – Pharmacodynamics; Hyperparathyroidism – Complications; Hyperparathyroidism – Drug Therapy; Osteoporosis – Drug Therapy; Osteoporosis – Etiology; Raloxifene – Therapeutic Use
Creator
An entity primarily responsible for making the resource
Dillon ML; Frazee L A
Description
An account of the resource
The objective of this article is to review the literature regarding the treatment of primary hyperparathyroidism (PHPT) with a focus on cinacalcet. A MEDLINE (1965-June 2009) and bibliographic search of the English-language literature was conducted using the search terms cinacalcet, calcimimetics, primary hyperparathyroidism, and treatment. All articles identified in the search were included. Parathyroidectomy is curative for patients with PHPT; however, there are few options for patients who are not surgical candidates, who refuse surgery, or those with refractory PHPT after parathyroidectomy. Possible treatment options include estrogens, raloxifene, bisphosphonates, calcitonin, and cinacalcet. Cinacalcet has been shown to decrease serum calcium and parathyroid hormone serum levels in patients with PHPT. These trials, however, have not studied the effect of cinacalcet on patient-oriented outcomes such as bone mineral density, nephrolithiasis, or other complications of PHPT. Cinacalcet may be considered to reduce serum calcium and parathyroid hormone serum levels in patients with PHPT who cannot or will not undergo surgery and those with refractory PHPT after parathyroidectomy. Because the effects of cinacalcet on bone mineral density are uncertain, more frequent monitoring of bone mineral density may be required along with a medication proven to improve bone mineral density. Future studies should evaluate the effect of cinacalcet on complications of PHPT.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1097/mjt.0b013e3181bdc3d0" target="_blank" rel="noreferrer noopener">10.1097/mjt.0b013e3181bdc3d0</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2011
American journal of therapeutics
Bone Density – Drug Effects
Calcitonin – Therapeutic Use
Department of Internal Medicine
Dillon ML
Diphosphonates – Therapeutic Use
Estrogens – Therapeutic Use
Female
Frazee L A
Hormone Antagonists – Pharmacodynamics
Hormone Antagonists – Therapeutic Use
Hormone Replacement Therapy
Hydrocarbons – Pharmacodynamics
Hydrocarbons – Therapeutic Use
Hyperparathyroidism – Complications
Hyperparathyroidism – Drug Therapy
NEOMED College of Medicine
Osteoporosis – Drug Therapy
Osteoporosis – Etiology
Raloxifene – Therapeutic Use
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1016/s0002-9629(15)40823-7" target="_blank" rel="noreferrer noopener">http://doi.org/10.1016/s0002-9629(15)40823-7</a>
Pages
214–218
Issue
3
Volume
320
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
A subtherapeutic international normalized ratio despite increasing doses of warfarin: could this be malabsorption?
Publisher
An entity responsible for making the resource available
The American journal of the medical sciences
Date
A point or period of time associated with an event in the lifecycle of the resource
2000
2000-09
Subject
The topic of the resource
*Drug Resistance; Administration; Adult; Anticoagulants/administration & dosage/metabolism/pharmacokinetics/therapeutic use; Area Under Curve; Biological Availability; Dose-Response Relationship; Drug; Female; Humans; Injections; Intestinal Absorption/*physiology; Intravenous; Kidney Transplantation; Oral; Warfarin/*administration & dosage/*metabolism/pharmacokinetics/therapeutic use
Creator
An entity primarily responsible for making the resource
Lara L F; Delgado L L; Frazee L A; Haupt K M; Rutecki G W
Description
An account of the resource
OBJECTIVE: To describe a case of warfarin resistance apparently caused by malabsorption and to review the literature regarding warfarin resistance. CASE SUMMARY: A 28-year-old renal transplant patient with systemic lupus erythematosus was admitted for upper extremity thrombophlebitis. Resistance to oral warfarin was demonstrated. Potential causes were investigated. The trapezoidal rule was used to compare the area under the curve for intravenous versus oral dosing of warfarin. The usual bioavailability of warfarin should be 100%. In this patient, warfarin bioavailability after oral dosing was 1.5%. Three potential causes, malabsorption (FF), enzymatic degradation (FG), and first-pass extraction in the portal circulation (FH), are discussed. CONCLUSION: This case demonstrates resistance to warfarin presumably caused by malabsorption.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1016/s0002-9629(15)40823-7" target="_blank" rel="noreferrer noopener">10.1016/s0002-9629(15)40823-7</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
*Drug Resistance
2000
Administration
Adult
Anticoagulants/administration & dosage/metabolism/pharmacokinetics/therapeutic use
Area Under Curve
Biological Availability
Delgado L L
Department of Family & Community Medicine
Department of Internal Medicine
Dose-Response Relationship
Drug
Female
Frazee L A
Haupt K M
Humans
Injections
Intestinal Absorption/*physiology
Intravenous
Kidney Transplantation
Lara L F
NEOMED College of Medicine
Oral
Rutecki G W
The American journal of the medical sciences
Warfarin/*administration & dosage/*metabolism/pharmacokinetics/therapeutic use